Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The entorhinal cortex layer II (EC-II) neurons are among the first neurons to develop tau pathology in Alzheimer's disease. These neurons project to the dentate gyrus via the perforant path and are critical for memory formation.
| Property |
Value |
| Cell Type |
Projection Neurons (Layer II) |
| Location |
Entorhinal Cortex, Layer II |
| Neurotransmitters |
Glutamate |
| Associated Diseases |
Alzheimer's Disease, Temporal Lobe Epilepsy |
| Model Systems |
Mouse entorhinal cortex slices, human iPSC-derived neurons |
Entorhinal cortex layer II neurons receive input from association cortices and project to the dentate gyrus granule cells via the perforant path. This circuit is essential for:
- Spatial memory encoding
- Pattern separation
- Memory consolidation
- Navigation and episodic memory
- EC-II neurons develop neurofibrillary tangles (NFTs) before any other cortical region [1]
- The EC is the entry point of tau into the hippocampal formation
- Layer II neurons show tau pathology before CA1 pyramidal cells
- Significant neuronal loss occurs in EC layer II in early AD [2]
- This loss correlates with memory deficits in early stages
- EC atrophy is detectable by MRI in MCI patients
- Disrupted perforant path signaling impairs dentate gyrus function
- Pattern separation deficits emerge early in AD
- Network oscillations (theta, gamma) are abnormal
- Hyperphosphorylated tau accumulates in EC-II neurons
- Specific tau strains may preferentially target these neurons
- Post-translational modifications (phosphorylation, acetylation) affect tau aggregation
- Gene expression profiling shows downregulation of synaptic proteins
- Mitochondrial dysfunction is evident in EC-II
- Upregulation of stress response genes
- EC represents the earliest therapeutic target for disease modification
- Tau-targeting therapies may need to reach EC neurons
- Neuroprotective strategies could preserve EC function
- CSF tau levels correlate with EC pathology
- PET ligands targeting tau show early EC uptake
- Structural MRI shows EC thinning in early AD
The study of Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Braak & Braak, 1991 - Neurofibrillary changes in the entorhinal cortex
- Gómez-Isla et al., 1996 - Neuronal loss in the entorhinal cortex in AD
- Khan et al., 2014 - Entorhinal cortex atrophy in early Alzheimer's disease